Tolerance and Acceptability Evaluation of MONACO
NCT03836274 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2020-01-07
Summary
To evaluate tolerance and acceptability of 'MONACO' in patients requiring supplementary oral nutritional support compared with currently available alternatives.
Conditions
- Malnutrition
Interventions
- DIETARY_SUPPLEMENT
-
AYMES MONACO
AYMES MONACO is a Food for Special Medical Purposes (FSMP) and must, therefore, be used under medical supervision. It is not designed as a sole source of nutrition.
Sponsors & Collaborators
-
Aymes International Limited
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-11-01
- Primary Completion
- 2020-01-01
- Completion
- 2020-01-01
Countries
- United Kingdom
Study Locations
More Related Trials
-
Study of SPM 962 in Patients With Restless Legs Syndrome (RLS)
NCT01084551 ·Status: COMPLETED ·Phase: PHASE3
-
Neural Stem Cell Treatment for Amyotrophic Lateral Sclerosis (STEMALS)
NCT06344260 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Determine the Safety, Pharmacokinetics, and Pharmacodynamics of DNL343 in Participants With Amyotrophic Lateral Sclerosis
NCT05006352 ·Status: COMPLETED ·Phase: PHASE1
-
Different Doses of Naronapride vs. Placebo in Gastroparesis
NCT05621811 ·Status: COMPLETED ·Phase: PHASE2
-
Bumetanide in Hypokalaemic Periodic Paralysis
NCT02582476 ·Status: TERMINATED ·Phase: PHASE2
-
Open-Label, Safety and Tolerability Extension Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL211)
NCT00931944 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT00072709 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral Sclerosis
NCT04176224 ·Status: COMPLETED ·Phase: PHASE1
-
Perampanel for Sporadic Amyotrophic Lateral Sclerosis (ALS)
NCT03019419 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Study in Adult Patients With Non-dystrophic Myotonic Disorders
NCT04616807 ·Status: ACTIVE_NOT_RECRUITING
-
Placebo Controlled Study of ONO2506PO in the Presence of Riluzole in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT00403104 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
NCT03019185 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Evaluate the Efficacy, Safety, and Tolerability of E2086 Compared to Placebo and Active Comparator in Adult Participants With Narcolepsy Type 1
NCT06462404 ·Status: COMPLETED ·Phase: PHASE1
-
Growth Hormone in Amyotrophic Lateral Sclerosis
NCT00635960 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Investigate the Efficacy and Safety of Mexiletine in Patients With Myotonic Dystrophy Type 1 and Type 2
NCT04700046 ·Status: WITHDRAWN ·Phase: PHASE3
-
Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Type I
NCT00439218 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
ALS Phase II Study of NX210c
NCT06365216 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD)
NCT04003974 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Efficacy, Safety and Pharmacokinetics of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy (SMA)
NCT01839656 ·Status: COMPLETED ·Phase: PHASE2
-
A Long-Term Extension Trial From Late Phase II of SPM 962 in Patients With Restless Legs Syndrome
NCT01562743 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacodynamic EffIcacy and Clinical Benefit of AT 007 in Patients With Sorbitol Dehydrogenase (SORD) Deficiency
NCT05397665 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
An Open-label Safety and Tolerability Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy Who Previously Participated in ISIS 396443-CS1 (NCT01494701)
NCT01780246 ·Status: COMPLETED ·Phase: PHASE1
-
A Placebo-Controlled Study for SPM 962 in Restless Legs Syndrome (RLS) Patients
NCT00666965 ·Status: COMPLETED ·Phase: PHASE2
-
A Long-term Extension Study of TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis(ALS)
NCT00230074 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis
NCT03677401 ·Status: COMPLETED ·Phase: PHASE3